J. CRAIG VENTER TO KEYNOTE at SYNBIOBETA SF 2014

SAN FRANCISCO, CA., 4th November 2014 / Sciad Newswire / SynBioBeta, the leading community within the synthetic biology field, announced that bio-pioneer J. Craig Venter PhD, will be this year’s keynote speaker at the 3rd Annual SynBioBeta SF 2014 conference, November 13th to 15th at Mission Bay Conference Center. Venter founded and leads the J. Craig Venter Institute, Synthetic Genomics, Inc., and Human Longevity, Inc. He will address attendees on Friday, November 14th.

“I am excited to welcome Craig Venter, one of the pioneering individuals and leading visionaries in the development of the field, into the SynBioBeta community,” said SynBioBeta Founder and CEO John Cumbers PhD. “The scientific and investment landscape would look much differently today if it were not for his dedication and perseverance to advancing biology as technology. We are all looking forward to learning about the most recent developments with his work and future opportunities extended to entrepreneurs designing and engineering biology.”

In its third year in the Bay Area, SynBioBeta SF is the leading event within the synthetic biology community. The conference provides a venue for startups, established companies, investors, and academics to meet, partner, exchange ideas, and learn about the latest advances in the rapidly evolving space. Various industries being disrupted by synthetic biology will be represented, including waste carbon manufacturing, DNA synthesis, flavor and fragrances, and more. In addition, the event will feature an investor roundtable and a lightning round of news, updates, and announcements from around the field, including companies taking part in a government sponsored trade mission from the United Kingdom.

Supporters of the conference include Autodesk, On-Point Capital, UK Trade and Investment, Genscript, and Cambrian Genomics.

SynBioBeta SF 2014 will kick-off with a Welcome Reception on Thursday, November 13th at the Autodesk Gallery, hosted by UK Trade and Investment, and will include an introduction to the 11 UK companies participating in the trade mission. On Saturday, November 15th, SynBioBeta will be presenting a Networking Brunch Cruise past the Golden Gate Bridge, open to anyone in the synthetic biology community to attend.

For more information on the conference, please contact Lisa Comeau, Director of Events, atlisa.comeau@synbiobeta.com, 650-479-5011, or visit www.synbiobeta.com.

For media inquiries, please contact Mikey Kelly at kelly@kfgroup.net, 415-328-3966, or Ed Fogelman, ed@kfgroup.net, 415-328-3969.

###

About SynBioBeta

SynBioBeta is the leading community of entrepreneurs, investors, service providers, policymakers, and biology enthusiasts devoted to the responsible growth of the synthetic biology field. It’s dedicated to telling the stories of the field and startups involved, building networks, and helping to attract investments. SynBioBeta’s international conferences and events bring the entire community together several times each year and give anyone the opportunity to meet with the bright minds building and shaping the nascent field — from venture capitalists and angel investors to entrepreneurs and thought leaders.